ASP2453
oral drug, covalent inhibitor of KRASG12C effective in KRASG12C-mutated cancer models SBDD utilizing KRAS proto-oncogene, GTPase British Journal of Cancer Astellas Pharma Inc.
Molecules of the Month - November 2021
Molecules of the Month
- paxlovid
- GS-621763
- ASP2453
- SY-5609
- BIIB091
- "compound Ia"
- DS96432529
- "compound 27"
- tepotinib
- PF-06939999
- "compound 5"
- compound 59
- M5717
- compound 1